115 related articles for article (PubMed ID: 37793743)
1. Egg consumption and risk of coronary artery disease, potential amplification by high genetic susceptibility: a prospective cohort study.
Xia X; Liu F; Huang K; Chen S; Li J; Cao J; Yang X; Liu X; Shen C; Yu L; Zhao Y; Zhao L; Li Y; Hu D; Huang J; Lu X; Gu D
Am J Clin Nutr; 2023 Oct; 118(4):773-781. PubMed ID: 37793743
[TBL] [Abstract][Full Text] [Related]
2. Genetic Predisposition, Sedentary Behavior, and Incident Coronary Artery Disease: A Prospective Chinese Cohort Study.
Hu C; Huang K; Cai C; Liu F; Li J; Hu D; Zhao Y; Liu X; Cao J; Chen S; Li H; Yu L; Li Y; Shen C; Huang J; Gu D; Lu X
Med Sci Sports Exerc; 2024 Jan; 56(1):103-109. PubMed ID: 37703277
[TBL] [Abstract][Full Text] [Related]
3. Genetic risk modifies the effect of long-term fine particulate matter exposure on coronary artery disease.
Li J; Liang F; Liu F; Li J; Huang K; Yang X; Chen S; Cao J; Shen C; Zhao L; Li Y; Hu D; Wang W; Wu J; Huang J; Lu X; Gu D
Environ Int; 2022 Dec; 170():107624. PubMed ID: 36402033
[TBL] [Abstract][Full Text] [Related]
4. Modification of coronary artery disease clinical risk factors by coronary artery disease polygenic risk score.
Truong B; Ruan Y; Haidermota S; Patel A; Surakka I; Hornsby W; Koyama S; Lee SH; Natarajan P
Med; 2024 May; 5(5):459-468.e3. PubMed ID: 38642556
[TBL] [Abstract][Full Text] [Related]
5. Predictive Utility of a Coronary Artery Disease Polygenic Risk Score in Primary Prevention.
Marston NA; Pirruccello JP; Melloni GEM; Koyama S; Kamanu FK; Weng LC; Roselli C; Kamatani Y; Komuro I; Aragam KG; Butterworth AS; Ito K; Lubitz SA; Ellinor PT; Sabatine MS; Ruff CT
JAMA Cardiol; 2023 Feb; 8(2):130-137. PubMed ID: 36576811
[TBL] [Abstract][Full Text] [Related]
6. A polygenic risk score improves risk stratification of coronary artery disease: a large-scale prospective Chinese cohort study.
Lu X; Liu Z; Cui Q; Liu F; Li J; Niu X; Shen C; Hu D; Huang K; Chen J; Xing X; Zhao Y; Lu F; Liu X; Cao J; Chen S; Ma H; Yu L; Wu X; Wu X; Li Y; Zhang H; Mo X; Zhao L; Huang J; Wang L; Wen W; Shu XO; Takeuchi F; Koh WP; Tai ES; Cheng CY; Wong TY; Chang X; Chan MY; Gao W; Zheng H; Chen K; Chen J; He J; Tang CS; Lam KSL; Tse HF; Cheung CYY; Takahashi A; Kubo M; Kato N; Terao C; Kamatani Y; Sham PC; Heng CK; Hu Z; Chen YE; Wu T; Shen H; Willer CJ; Gu D
Eur Heart J; 2022 May; 43(18):1702-1711. PubMed ID: 35195259
[TBL] [Abstract][Full Text] [Related]
7. Polygenic risk score and coronary artery disease: A meta-analysis of 979,286 participant data.
Agbaedeng TA; Noubiap JJ; Mofo Mato EP; Chew DP; Figtree GA; Said MA; van der Harst P
Atherosclerosis; 2021 Sep; 333():48-55. PubMed ID: 34425527
[TBL] [Abstract][Full Text] [Related]
8. Associations of combined polygenic risk score and glycemic status with atrial fibrillation, coronary artery disease and ischemic stroke.
Kim J; Kim D; Bae HJ; Park BE; Kang TS; Lim SH; Lee SY; Chung YH; Ryu JW; Lee MY; Yang PS; Joung B
Cardiovasc Diabetol; 2024 Jan; 23(1):5. PubMed ID: 38172896
[TBL] [Abstract][Full Text] [Related]
9. Contribution of Lipoprotein(a) to Polygenic Risk Prediction of Coronary Artery Disease: A Prospective UK Biobank Analysis.
Manikpurage HD; Paulin A; Girard A; Eslami A; Mathieu P; Thériault S; Arsenault BJ
Circ Genom Precis Med; 2023 Oct; 16(5):470-477. PubMed ID: 37753708
[TBL] [Abstract][Full Text] [Related]
10. Limitations of Contemporary Guidelines for Managing Patients at High Genetic Risk of Coronary Artery Disease.
Aragam KG; Dobbyn A; Judy R; Chaffin M; Chaudhary K; Hindy G; Cagan A; Finneran P; Weng LC; Loos RJF; Nadkarni G; Cho JH; Kember RL; Baras A; Reid J; Overton J; Philippakis A; Ellinor PT; Weiss ST; Rader DJ; Lubitz SA; Smoller JW; Karlson EW; Khera AV; Kathiresan S; Do R; Damrauer SM; Natarajan P
J Am Coll Cardiol; 2020 Jun; 75(22):2769-2780. PubMed ID: 32498804
[TBL] [Abstract][Full Text] [Related]
11. Polygenic Hyperlipidemias and Coronary Artery Disease Risk.
Ripatti P; Rämö JT; Mars NJ; Fu Y; Lin J; Söderlund S; Benner C; Surakka I; Kiiskinen T; Havulinna AS; Palta P; Freimer NB; Widén E; Salomaa V; Tukiainen T; Pirinen M; Palotie A; Taskinen MR; Ripatti S;
Circ Genom Precis Med; 2020 Apr; 13(2):e002725. PubMed ID: 32154731
[TBL] [Abstract][Full Text] [Related]
12. Coronary Artery Disease-Associated and Longevity-Associated Polygenic Risk Scores for Prediction of Coronary Artery Disease Events in Persons Living With Human Immunodeficiency Virus: The Swiss HIV Cohort Study.
Schoepf IC; Thorball CW; Ledergerber B; Engel T; Raffenberg M; Kootstra NA; Reiss P; Hasse B; Marzolini C; Thurnheer C; Seneghini M; Bernasconi E; Cavassini M; Buvelot H; Kouyos R; Günthard HF; Fellay J; Tarr PE;
Clin Infect Dis; 2021 Nov; 73(9):1597-1604. PubMed ID: 34091660
[TBL] [Abstract][Full Text] [Related]
13. Reproducible disease phenotyping at scale: Example of coronary artery disease in UK Biobank.
Patel RS; Denaxas S; Howe LJ; Eggo RM; Shah AD; Allen NE; Danesh J; Hingorani A; Sudlow C; Hemingway H
PLoS One; 2022; 17(4):e0264828. PubMed ID: 35381005
[TBL] [Abstract][Full Text] [Related]
14. Polygenic Risk Scores for Prediction of Subclinical Coronary Artery Disease in Persons With Human Immunodeficiency Virus (HIV): The Swiss HIV Cohort Study.
Schoepf IC; Thorball CW; Kovari H; Ledergerber B; Buechel RR; Calmy A; Weber R; Kaufmann PA; Nkoulou R; Schwenke JM; Braun DL; Fellay J; Tarr PE;
Clin Infect Dis; 2023 Jan; 76(1):48-56. PubMed ID: 36097729
[TBL] [Abstract][Full Text] [Related]
15. Risk prediction for coronary heart disease by a genetic risk score - results from the Heinz Nixdorf Recall study.
Pechlivanis S; Lehmann N; Hoffmann P; Nöthen MM; Jöckel KH; Erbel R; Moebus S
BMC Med Genet; 2020 Sep; 21(1):178. PubMed ID: 32912153
[TBL] [Abstract][Full Text] [Related]
16. Integrating a Polygenic Risk Score for Coronary Artery Disease as a Risk-Enhancing Factor in the Pooled Cohort Equation: A Cost-Effectiveness Analysis Study.
Mujwara D; Henno G; Vernon ST; Peng S; Di Domenico P; Schroeder B; Busby GB; Figtree GA; Bottà G
J Am Heart Assoc; 2022 Jun; 11(12):e025236. PubMed ID: 35699184
[TBL] [Abstract][Full Text] [Related]
17. Patients With High Genome-Wide Polygenic Risk Scores for Coronary Artery Disease May Receive Greater Clinical Benefit From Alirocumab Treatment in the ODYSSEY OUTCOMES Trial.
Damask A; Steg PG; Schwartz GG; Szarek M; Hagström E; Badimon L; Chapman MJ; Boileau C; Tsimikas S; Ginsberg HN; Banerjee P; Manvelian G; Pordy R; Hess S; Overton JD; Lotta LA; Yancopoulos GD; Abecasis GR; Baras A; Paulding C;
Circulation; 2020 Feb; 141(8):624-636. PubMed ID: 31707832
[TBL] [Abstract][Full Text] [Related]
18. Interaction between genetics and smoking in determining risk of coronary artery diseases.
Huang Y; Hui Q; Gwinn M; Hu YJ; Quyyumi AA; Vaccarino V; Sun YV
Genet Epidemiol; 2022 Apr; 46(3-4):199-212. PubMed ID: 35170807
[TBL] [Abstract][Full Text] [Related]
19. Subtyping Severe Hypercholesterolemia by Genetic Determinant to Stratify Risk of Coronary Artery Disease.
Berry ASF; Jones LK; Sijbrands EJ; Gidding SS; Oetjens MT
Arterioscler Thromb Vasc Biol; 2023 Oct; 43(10):2058-2067. PubMed ID: 37589137
[TBL] [Abstract][Full Text] [Related]
20. Associations of egg and cholesterol intakes with carotid intima-media thickness and risk of incident coronary artery disease according to apolipoprotein E phenotype in men: the Kuopio Ischaemic Heart Disease Risk Factor Study.
Virtanen JK; Mursu J; Virtanen HE; Fogelholm M; Salonen JT; Koskinen TT; Voutilainen S; Tuomainen TP
Am J Clin Nutr; 2016 Mar; 103(3):895-901. PubMed ID: 26864369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
